Dualtera Tablet 60/5 mg
Fimasartan Potassium Trihydrate 66.01mg · S-Amlodipine Besylate 2.5 Hydrate 7.48mg
Tablet · Prescription medication · Combination
JW Pharmaceutical Co., Ltd.
MFDS item code 202300094 · Approved 2023.01.06
This product's status changed to Approval withdrawn on 2024.02.20. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of essential hypertension not adequately controlled with fimasartan monotherapy
Used for patients with essential hypertension whose blood pressure is not adequately controlled by monotherapy with Pimasartan.
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). It is recommended that the dose be adjusted using fimasartan before starting this medicine; however, if blood pressure is not controlled as described below, switching directly to this medicine may be considered. ㆍ 30/2.5 milligrams: Administer to patients whose blood pressure is not adequately controlled with fimasartan 30 milligrams as monotherapy. ㆍ 60/2.5 milligrams: Administer to patients whose blood pressure is not adequately controlled with fimasartan 60 milligrams as monotherapy. ㆍ 60/5 milligrams: Administer to patients whose blood pressure is not adequately controlled with fimasartan 60 milligrams as monotherapy or this medicine 60/2.5 milligrams. Patients taking fimasartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience. Elderly patients No initial dosage adjustment is necessary for elderly patients 70 years of age or younger. Patients with renal impairment No dosage adjustment is necessary in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min); however, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment should be initiated with fimasartan 30 milligrams in this medicine. Patients with hepatic impairment No dosage adjustment is necessary in patients with mild hepatic impairment; however, this medicine should not be administered to patients with moderate to severe hepatic impairment.
The safety and efficacy of this medicine in pediatric and adolescent patients 18 years of age or younger have not been established.
This medication can cause serious harm to the fetus and newborn if taken during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately if pregnancy is confirmed. Patients allergic to any ingredients of this medication, pregnant or breastfeeding women, patients undergoing renal dialysis, patients with moderate to severe liver impairment, and those with bile duct obstruction should not take this medication. In addition, patients with diabetes or severely impaired renal function, certain genetically lactose-intolerant patients, those with severe aortic stenosis, and patients in shock are also prohibited from taking this medication. Particular caution is required when using this medication in patients with decreased blood volume or sodium deficiency, impaired renal function, renovascular hypertension, heart valve disease, older adults, etc. This medication may cause side effects such as dizziness, headache, swelling, urination problems, insomnia, and facial flushing; consultation with a doctor is necessary if any abnormal symptoms occur. Patients with low blood pressure or electrolyte imbalance may experience symptoms of hypotension when starting this medication or increasing the dose, so caution is necessary, and regular monitoring of serum potassium levels is recommended. This medication may interact with other drugs; therefore, it is essential to inform your doctor, especially if you are taking potassium-sparing diuretics, other antihypertensive medications, lithium, or non-steroidal anti-inflammatory drugs. Use of this medication during pregnancy may pose risks to the fetus, so do not take it if you are planning a pregnancy or are pregnant; it is also not recommended for breastfeeding mothers. The safety of this medication has not been established for children and adolescents under 18, so its use is not recommended. For older adults, no special dose adjustment is necessary, but caution is advised as their body responses may be more sensitive. Patients with moderate to severe liver impairment should not take this medication. In cases of overdose, hypotension, arrhythmia, and in severe cases, shock may occur, so immediate medical attention is required. Store this medication out of the reach of children and do not transfer it to another container; it is essential to follow your doctor's instructions when using it.
Not everyone experiences these, and they can vary from person to person.
This medication can be sensitive to light; therefore, it should be stored in a special container that protects it from light. Additionally, it is essential to maintain a temperature between 1 and 30 degrees Celsius while storing the medication. This helps to preserve the efficacy of the medication.
Orange, rounded rectangular film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Fimasartan Potassium Trihydrate 66.01mg · S-Amlodipine Besylate 2.5 Hydrate 7.48mg
Tablet · Prescription medication · Combination
JW Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 66.01mg · S-Amlodipine Besylate 2.5 Hydrate 7.48mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 66.01mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
NBK Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Ajou Pharmaceuticals Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Kips Biopharma Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Bionex Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.